The Fifth International Workshop on peritoneal surface malignancy (Milan, Italy, December 4-6, 2006): Methodology of disease-specific consensus

Journal of Surgical Oncology

Volumn 98, Issue 4, 2008, Pages 258-262

  Baratti, Dario ^a   Kusamura, Shigeki ^a   Deraco, Marcello ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Consensus; Cytoreductive surgery; HIPEC; Hyperthermic intraperitoneal chemotherapy; Peritoneal surface malignancies

Indexed keywords

ABDOMINAL SARCOMATOSIS; APPENDICEAL CARCINOMATOSIS; APPENDIX TUMOR; COLORECTAL CANCER; COLORECTAL CARCINOMATOSIS; CONFERENCE PAPER; CONSENSUS; CYTOREDUCTIVE SURGERY; DELPHI STUDY; EVALUATION; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTRIC CARCINOMATOSIS; METHODOLOGY; OVARY CANCER; OVARY CARCINOMATOSIS; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PRIORITY JOURNAL; STOMACH CANCER; WEB BROWSER;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CONSENSUS; DELPHI TECHNIQUE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; PERITONEAL NEOPLASMS;

EID: 50849130946     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21056     Document Type: Conference Paper

References (23)

1. González-Moreno S: Peritoneal surface oncology: A progress report. Eur J Surg Oncol 2006;32:593-596.
2. Jones J, Hunter D: Consensus methods for medical and health services research. Br Med J 1995;311:376-380.
3. Casali P, Licitra L, Tondini C, et al.: START: A European state-of-the-art on-line instrument for clinical oncologists. Ann Oncol 1999;10:769-773.
4. Esquivel J, Sticca R, Sugarbaker P, et al.: Society of Surgical Oncology Annual Meeting. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement. Society of Surgical Oncology. Ann Surg Oncol 2007;14:128-133.
5. Sugarbaker PH: Peritonectomy procedures. Ann Surg 1995;221:29-42.
6. Stewart JH IV, Shen P, Levine EA: Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Current status and future directions. Ann Surg Oncol 2005;12:765-777.
7. Boyle P, Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-488.
8. Koppe MJ, Boerman OC, Oyen WJG, et al.: Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg 2006;243:212-222.
9. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
10. Moriguchi S, Maehara Y, Korenaga D, et al.: Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1992;1:341-346.
11. Sugarbaker PH: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006;7:69-76.
12. Deraco M, Baratti D, Zaffaroni N, et al.: Advances in clinical research and management of diffuse peritoneal mesothelioma. Recent Results Cancer Res 2007;169:137-155.
13. Sadeghi B, Arvieux C, Glehen O, et al.: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88: 358-363.
14. Yan TD, Welch L, Black D, et al.: A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Oncol 2007;18:827-834.
15. Yan TD, Black D, Sugarbaker PH, et al.: A systematic review and meta-analysis of the randomized controlled on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007;14:2702-2713.
16. McGuire WP, Hoskins WJ, Brady MF, et al.: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
17. Yan TD, Black D, Savady R, et al.: A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 2007;14:484-492.
18. Sugarbaker PH, Yan TD, Stuart OA, et al.: Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 2006;32:686-691.
19. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2003;21:37-43.
20. Armstrong DK, Bundy B, Wenzel L, et al.: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:77-79.
21. Bonvalot S, Cavalcanti A, Le Péchoux C, et al.: Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol 2005;31:917-923.
22. Rankin C, Von Mehren M, Blanke C, et al.: Dose effect of imatinib in patients with metastatic GIST: Phase III sarcoma group studyS0033. J Clin Oncol 2004;22:819.
23. Keeney S, Hasson F, McKenna H: Consulting the oracle: Ten lessons from using the Delphi technique in nursing research. J Adv Nurs 2006;53:205-212.